Fresno, CA, United States of America

Taher Hegab

This inventor holds 1 USPTO granted patent. Top assignees: Health Research, Inc., The State University of New York. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Taher Hegab. Retrieved from https://idiyas.com/inventor/taher-hegab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Taher Hegab: Innovator in Chemical Compounds

Introduction

Taher Hegab is a notable inventor based in Fresno, California. He has made significant contributions to the field of chemical compounds, particularly in the development of azepans and their applications in medical treatments. His work focuses on modulating cell proliferation and apoptosis, which is crucial in the fight against cancers and other proliferative diseases.

Latest Patents

Taher Hegab holds a patent for "Azepans and methods for making and using same." This patent discloses compounds characterized by specific formulas, where Z is an alkylene moiety, Q is a carboxylic acid derivative, and R and R' are selected from various groups including alkyl and aryl. These compounds have potential applications in treating various diseases by modulating cell behavior.

Career Highlights

Throughout his career, Taher Hegab has worked with esteemed institutions such as the State University of New York and Health Research, Inc. His research has contributed to advancements in the understanding and treatment of proliferative diseases.

Collaborations

Some of his notable coworkers include David G Hangauer and Fengzhi Li. Their collaborative efforts have furthered research in the field of chemical compounds and their applications.

Conclusion

Taher Hegab's innovative work in the development of azepans showcases his commitment to advancing medical science. His contributions are vital in the ongoing battle against cancer and other proliferative conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…